|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.895 SEK | -0.52% |
|
-0.26% | -0.26% |
| 20/07 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 16/07 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 46Cr 40Cr 38Cr 34Cr 64Cr 4.41TCr 65Cr 439.88Cr 172.34Cr 2.21TCr 173.62Cr 169.84Cr 7.36TCr | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 43Cr 37Cr 35Cr 32Cr 60Cr 4.1TCr 61Cr 409.33Cr 160.38Cr 2.05TCr 161.56Cr 158.04Cr 6.85TCr | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.52% | ||
| 1 week | -0.26% | ||
| Current month | +2.16% | ||
| 1 month | -19.70% | ||
| 3 months | -26.26% | ||
| 6 months | +7.06% | ||
| Current year | -0.26% |
| 1 week | 1.8 |  | 1.92 |
| 1 month | 1.61 | | 2.5 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12.12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% | ||
| 27/12/25 | Buy | Chairman | 30,000 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -0.26% | -27.39% | -30.59% | 4.87Cr | |
| -0.67% | +9.52% | +92.36% | +131.30% | 1,09800Cr | |
| -0.83% | +1.72% | +49.19% | +49.16% | 63TCr | |
| +0.69% | +2.11% | +25.33% | +63.59% | 44TCr | |
| -1.13% | +3.13% | +49.78% | +39.13% | 37TCr | |
| -0.74% | +1.01% | +31.08% | +38.64% | 30TCr | |
| -1.22% | +0.89% | +7.32% | +7.38% | 25TCr | |
| -0.72% | +6.27% | +45.38% | +57.88% | 23TCr | |
| +0.34% | -0.13% | -4.77% | -50.50% | 21TCr | |
| +2.45% | +0.71% | +13.06% | +70.26% | 16TCr | |
| Average | -0.17% | +1,491.68% | +28.13% | +37.63% | 36.84TCr | |
| Weighted average by Cap. | -0.36% | +1,331.48% | +50.04% | +66.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.56Cr 3.95Cr 3.7Cr 3.37Cr 6.35Cr 434.69Cr 6.46Cr 43Cr 17Cr 217.57Cr 17Cr 17Cr 725.86Cr | 5.39Cr 4.67Cr 4.37Cr 3.99Cr 7.51Cr 514.12Cr 7.63Cr 51Cr 20Cr 257.33Cr 20Cr 20Cr 858.5Cr |
| Net income | -5.32Cr -4.61Cr -4.31Cr -3.94Cr -7.41Cr -507.22Cr -7.53Cr -51Cr -20Cr -253.87Cr -20Cr -20Cr -846.97Cr | -5.19Cr -4.5Cr -4.21Cr -3.84Cr -7.23Cr -494.92Cr -7.35Cr -49Cr -19Cr -247.72Cr -19Cr -19Cr -826.44Cr |
| Net Debt | -7.3Cr -6.33Cr -5.92Cr -5.4Cr -10Cr -696.37Cr -10Cr -69Cr -27Cr -348.55Cr -27Cr -27Cr -1.16TCr | -3.21Cr -2.78Cr -2.61Cr -2.38Cr -4.47Cr -306.27Cr -4.55Cr -31Cr -12Cr -153.3Cr -12Cr -12Cr -511.43Cr |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | SEK 1.895 | -0.52% | 23,993 |
| 10/26/10 | SEK 1.905 | +1.60% | 18,676 |
| 07/26/07 | SEK 1.875 | +1.63% | 50,964 |
| 06/26/06 | SEK 1.845 | +0.54% | 57,243 |
| 05/26/05 | SEK 1.835 | -3.42% | 79,704 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
